Diagnostic properties of metabolic perturbations in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 13, Issue 1, 2011, Pages

  Madsen, Rasmus K ^a   Lundstedt, Torbjörn ^b,c   Gabrielsson, Jon ^c   Sennbro, Carl Johan ^d   Alenius, Gerd Marie ^e   Moritz, Thomas ^f   Rantapää Dahlqvist, Solbritt ^e   Trygg, Johan ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c AcureOmics AB   (Sweden)

^d Active Biotech Research AB   (Sweden)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BIOLOGICAL MARKER; CHOLESTEROL; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLYCERIC ACID; HISTIDINE; HYPOXANTHINE; METHIONINE; THREONINE;

ADULT; AGED; ARTICLE; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; METABOLIC PARAMETERS; METABOLOMICS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; ADOLESCENT; BLOOD; MASS FRAGMENTOGRAPHY; METHODOLOGY; MIDDLE AGED; VALIDATION STUDY;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOMICS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 79551689052     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3243     Document Type: Article

References (39)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
2. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007, 7:429-442. 10.1038/nri2094, 17525752.
3. Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. TNF α is an effective therapeutic target for rheumatoid arthritis. Ann N Y Acad Sci 1995, 766:272-278. 10.1111/j.1749-6632.1995.tb26675.x, 7486670.
4. Visser H. Early diagnosis of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2005, 19:55-72. 10.1016/j.berh.2004.08.005, 15588971.
5. Harrison BJ, Symmons DPM, Barrett EM, Silman AJ. The performance of the 1987 ARA classification criteria for rheumatoid arthritis in a population based cohort of patients with early inflammatory polyarthritis. J Rheumatol 1998, 25:2324-2330.
6. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749.
7. Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides. J Rheumatol 2008, 35:1002-1008.
8. Van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005, 7:R949-R958. 10.1186/ar1767, 1257421, 16207336.
9. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B, Group BS. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004, 63:1090-1095. 10.1136/ard.2003.014233, 1755129, 15308518.
10. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, Kamae I, Kumagai S. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007, 146:797-808.
11. Madsen R, Lundstedt T, Trygg J. Chemometrics in metabolomics: a review in human disease diagnosis. Anal Chim Acta 2010, 659:23-33. 10.1016/j.aca.2009.11.042, 20103103.
12. Fernie AR, Trethewey RN, Krotzky AJ, Willmitzer L. Metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol 2004, 5:763-769. 10.1038/nrm1451, 15340383.
13. Trygg J, Holmes E, Lundstedt T. Chemometrics in metabonomics. J Proteome Res 2007, 6:469-479. 10.1021/pr060594q, 17269704.
14. A J, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz T. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 2005, 77:8086-8094. 10.1021/ac051211v, 16351159.
15. Jonsson P, Johansson AI, Gullberg J, Trygg J, A J, Grung B, Marklund S, Sjostrom M, Antti H, Moritz T. High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses. Anal Chem 2005, 77:5635-5642. 10.1021/ac050601e, 16131076.
16. Redestig H, Fukushima A, Stenlund H, Moritz T, Arita M, Saito K, Kusano M. Compensation for systematic cross-contribution improves normalization of mass spectrometry based metabolomics data. Anal Chem 2009, 81:7974-7980. 10.1021/ac901143w, 19743813.
17. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003, 19:185-193. 10.1093/bioinformatics/19.2.185, 12538238.
18. Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS). J Chemom 2002, 16:119-128.
19. Eriksson LJ, Johansson E, Kettaneh-Wold N, Wold S. Multi- and Megavariate Data Analysis: Principles and Applications 2001, Umeå, Sweden: Umetrics Academy, 1.
20. Bylesjö M, Rantalainen M, Cloarec O, Nicholson JK, Holmes E, Trygg J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J Chemom 2006, 20:341-351.
21. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
22. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973, 3:55-78. 10.1016/0049-0172(73)90035-8, 4581554.
23. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673. 10.1002/art.21972, 16871531.
24. Van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LA, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LB. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990, 49:916-920. 10.1136/ard.49.11.916, 1004262, 2256738.
25. Stenlund H, Johansson E, Gottfries J, Trygg J. Unlocking interpretation in near infrared multivariate calibrations by orthogonal partial least squares. Anal Chem 2009, 81:203-209. 10.1021/ac801803e, 19117451.
26. Keun HC, Ebbels TMD, Antti H, Bollard ME, Beckonert O, Holmes E, Lindon JC, Nicholson JK. Improved analysis of multivariate data by variable stability scaling: application to NMR-based metabolic profiling. Anal Chim Acta 2003, 490:265-276.
27. Wold S. Cross-validatory estimation of the number of components in factor and principal components models. Technometrics 1978, 20:397-405.
28. Lindgren F, Geladi P, Rannar S, Wold S. Interactive variable selection (IVS) for PLS. 1. Theory and algorithms. J Chemom 1994, 8:349-363.
29. Minami Y, Kasukawa T, Kakazu Y, Iigo M, Sugimoto M, Ikeda S, Yasui A, van der Horst GTJ, Soga T, Ueda HR. Measurement of internal body time by blood metabolomics. Proc Natl Acad Sci USA 2009, 106:9890-9895. 10.1073/pnas.0900617106, 2689311, 19487679.
30. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, Saude EJ, Lix B, Adamko DJ, Shah S, Greiner R, Sykes BD, Marrie TJ. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem 2007, 79:6995-7004. 10.1021/ac0708588, 17702530.
31. Van Velzen EJJ, Westerhuis JA, van Duynhoven JPM, van Dorsten FA, Grün CH, Jacobs DM, Duchateau G, Vis DJ, Smilde AK. Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. J Proteome Res 2009, 8:3317-3330. 10.1021/pr801071p, 19374449.
32. Wishart DS. Metabolomics: applications to food science and nutrition research. Trends Food Sci Technol 2008, 19:482-493.
33. Sitton NG, Dixon JS, Bird HA, Wright V. Serum and synovial fluid histidine: a comparison in rheumatoid arthritis and osteoarthritis. Rheumatol Int 1986, 6:251-254. 10.1007/BF00541315, 3809887.
34. Rantapää-Dahlqvist S, Wållberg-Jonsson S, Dahlén G. Lipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritis. Ann Rheum Dis 1991, 50:366-368. 1004438, 1829348.
35. Jonsson SW, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Dahlqvist SR. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001, 28:2597-2602.
36. Van Halm VP, Nielen MMJ, Nurmohamed MT, van Schaardenburg D, Reesink HW, Voskuyl AE, Twisk JWR, van de Stadt RJ, de Koning M, Habibuw MR, van der Horst-Bruinsma IE, Dijkmans BAC. Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis. Ann Rheum Dis 2007, 66:184-188. 10.1136/ard.2006.051672, 1798498, 16760255.
37. Peters RA, Davenport HW. Vitamin C (ascorbic acid, cevitamic acid). Ann Rev Biochem 1938, 7:325-334.
38. Mäki-Petäjä KM, Cheriyan J, Booth AD, Hall FC, Brown J, Wallace SM, Ashby MJ, McEniery CM, Wilkinson IB. Inducible nitric oxide synthase activity is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol 2008, 129:399-405.
39. Corraliza I, Moncada S. Increased expression of arginase II in patients with different forms of arthritis: implications of the regulation of nitric oxide. J Rheumatol 2002, 29:2261-2265.